Creative Edge Nutrition Inc. (FITX) Announces the
Post# of 56324
Posted On: 05/12/2014 9:06:16 AM
Creative Edge Nutrition Inc. (FITX) Announces the Purchase and Build-Out of a Second Proposed Medical Marijuana Facility
Creative Edge Nutrition Inc. (FITX) Announces the Purchase and Build-Out of a Second Proposed Medical Marijuana Facility
MADISON HEIGHTS, MI--(Marketwired - May 12, 2014) - Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX), today announced with great pleasure that our subsidiary CEN Biotech Inc. purchased a 25 acre site in Lakeshore, Ontario (approximately 1/4 mile from our main site). The site is located at 135 North Rear Rd. The site is nearly complete and we will call for pre-license inspection on it within a few weeks. This is an independent and separate application from our site at 20 North Rear Rd, Lakeshore, Ontario. This will also be a standalone fully functional facility; a smaller model of our building one site one standalone model. It will be a cGMP/ USP 797 facility and have a similar workflow model to our main site. We have applied for the license to grow and sell marijuana and will be applying for the license to grow hemp on the site and conduct hemp trials.
"We purchased the site with the intentions of operating a research and development facility with respect to strain genetics, new grow techniques and bio-medical research," commented Bill Chaaban, President & CEO. "It has been our intention to not only grow and sell medical marijuana, but to be leaders in the forefront of medical marijuana research; In particular, to further identify treatment modalities for specific disease states based on strain selection. We intend to develop and own the intellectual property."
Dr. Sam Alawieh, Dr. David Felten and their medical advisory board will be instrumental in this research.
Creative Edge Nutrition Inc. (FITX) Announces the Purchase and Build-Out of a Second Proposed Medical Marijuana Facility
MADISON HEIGHTS, MI--(Marketwired - May 12, 2014) - Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX), today announced with great pleasure that our subsidiary CEN Biotech Inc. purchased a 25 acre site in Lakeshore, Ontario (approximately 1/4 mile from our main site). The site is located at 135 North Rear Rd. The site is nearly complete and we will call for pre-license inspection on it within a few weeks. This is an independent and separate application from our site at 20 North Rear Rd, Lakeshore, Ontario. This will also be a standalone fully functional facility; a smaller model of our building one site one standalone model. It will be a cGMP/ USP 797 facility and have a similar workflow model to our main site. We have applied for the license to grow and sell marijuana and will be applying for the license to grow hemp on the site and conduct hemp trials.
"We purchased the site with the intentions of operating a research and development facility with respect to strain genetics, new grow techniques and bio-medical research," commented Bill Chaaban, President & CEO. "It has been our intention to not only grow and sell medical marijuana, but to be leaders in the forefront of medical marijuana research; In particular, to further identify treatment modalities for specific disease states based on strain selection. We intend to develop and own the intellectual property."
Dr. Sam Alawieh, Dr. David Felten and their medical advisory board will be instrumental in this research.
(0)
(0)